Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging
Clinical trial NCT07527806 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07527806
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2029-05-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.